The former CEO of a California-based diagnostic device company was sentenced April 12 to seven years in prison after pleading guilty to securities fraud and obstructing an agency proceeding in connection with his fraudulent claims that the firm had developed a rapid test to detect the virus that causes COVID-19. The scheme allegedly resulted in $28 million in investor losses (... Read More